tiprankstipranks
Trending News
More News >
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market

Compare Diamedica Therapeutics (DMAC) vs. Competitors

Compare
570 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Diamedica Therapeutics
$7.18
$373.92M
-9.89
24.44%
3 Buy
0 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.89
$36.49M
-16.53
-74.72%
2 Buy
0 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$30.56
$1.66B
-11.68
130.99%
8 Buy
0 Hold
0 Sell
Strong Buy
Rocket Pharmaceuticals
$4.87
$528.73M
-2.29
-44.41%
7 Buy
3 Hold
1 Sell
Moderate Buy
Benitec Biopharma
$12.01
$412.60M
-19.77%
2 Buy
0 Hold
0 Sell
Moderate Buy
Annexon Biosciences
$5.72
$827.85M
-2.07
120.00%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DMAC
Diamedica Therapeutics
7.18
1.97
37.81%
TVRD
Tvardi Therapeutics
3.89
-11.71
-75.06%
CAPR
Capricor Therapeutics
30.56
18.95
163.22%
RCKT
Rocket Pharmaceuticals
4.87
-3.48
-41.68%
BNTC
Benitec Biopharma
12.01
-3.51
-22.62%
ANNX
Annexon Biosciences
5.72
3.22
128.80%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts